Received Feb 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | EK225 | — |
Expired dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number EK225, expiry date 10-MAR-2027) and (batch number 3959S, expiry date 12-DEC-2025) for prophylaxis. Previously administered products included Shingrix (received 1st dose of vaccine on 23-OCT-2025 with batch number EK225 and expiry date 10-MAR-2027). On 03-FEB-2026, the patient received the 2nd dose of Shingrix. On 03-FEB-2026, an unknown time after receiving Shingrix, the patient experienced expired vaccine used (Verbatim: Expired dose administered). The outcome of the expired vaccine used was not applicable.